---
$id: https://graph.org.ai/products/commodity/51111656
$type: Product
source: UNSPSC
code: "51111656"
title: "Tegafur"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tegafur

**UNSPSC Code**: 51111656
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a thymidylate synthase inhibitor and pyrimidine antagonist with the molecular formula C8H9FN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1548R74NSZ, chemically known as 2,4(1h,3h)-pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-, (r)- but generally known as tegafur, which bears US NIH Compound Identifier 5386. European Medicines Agency schedules Tegafur in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10870MIG. The term TEGAFUR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). World Health Organization schedules tegafur in its Anatomical Therapeutic Chemical (ATC) Classification. TEGAFUR is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tegafur under HS 29349990 and SITC 51579. As of Q4 2014, TEGAFUR remains the US FDA Preferred Term for this commodity. Tegafur bears US NLM identifiers UMLS ID C0016778 and NCI Concept Code C513. SMILES: FC1CN(C2OCCC2)C(=O)[NH]C1=O.

